HopeStage
Back to overview

Depression studies

Topics
More filters

Depression

Depression involves persistent low mood or loss of interest, often with tiredness and changes in sleep or appetite.

7264studies shown
Showing 1,993-2,004 of 7,264
Drug study icon
CompletedEUCTR 2004-002156-34

Double-blind, placebo-controlled trial investigating the safety of re-exposure to 900 mg of Org 34517, used as adjunctive therapy in subjects with psychotic major depression (major depressive episo...

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In Czech Republic
Depression, SchizophreniaHistorical research record
Countries
Czechia
Sponsor
NV Organon
Other study type icon
CompletedNCT05841030

A Study in people with Major Depressive Disorder (MDD) With Anhedonia and Inadequate Response to Current Antidepressant Therapy Including a Selective Serotonin Reuptake Inhibitor (SSRI) or Serotonin Norepinephrine Reuptake Inhibitor (SNRI)

Official study title

A Study of Disease Characteristics and Real-life Standard of Care Effectiveness in Patients With Major Depressive Disorder (MDD) With Anhedonia and Inadequate Response to Current Antidepressant Therapy Including an SSRI or SNRI

This study has finished and is no longer accepting participants.

Multiple locations, including Birmingham
DepressionObservational studyAges 18–74
Countries
United States, France, Canada, + 8 others
Sponsor
Janssen Research & Development, LLC
Other study type icon
WithdrawnNCT04829669

Participants With Moderate or Severe Major Depressive Disorder Requiring Urgent Symptom Control for depression

Official study title

Prospective Study to Assess, Outcomes and Healthcare Resource Use of Current Standard of Care for Patients With Moderate or sEvere MDD Requiring Urgent Symptom Control in a Psychiatric Emergency: POWER

This study was withdrawn before enrollment.

Location not clearly listed
DepressionObservational studyAges 18–64
Countries
Sponsor
Janssen-Cilag Ltd.

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.